Michael Aberman is an Adjunct Partner for IndieBio New York. He recruits companies, identifies mentors, and actively advises founders throughout the accelerator program.
Michael was the CEO & President of Quentis Therapeutics, a venture-backed oncology company. He previously served over 7 years as Senior Vice President of Strategy and Investor Relations at Regeneron. He also currently serves as Executive in Residence at Columbia Technology Ventures.
He started his career at an immuno-oncology focused bio-tech startup, and then worked on Wall Street at Morgan Stanley and Credit Suisse conducting biotech equity research.
Michael has a medical degree from the University of Toronto and an M.B.A. from the Wharton School of Business.